Allurion Technologies, Inc. Inventory Write-down
Allurion Technologies, Inc. (ALUR) reported Inventory Write-down of $433.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2026-05-15
- Allurion Technologies, Inc. inventory write-down for the quarter ending 2026-03-31 was $433.00K, a 1632.00% increase year-over-year.
- Allurion Technologies, Inc. inventory write-down for the quarter ending 2025-12-31 was $717.00K, a 39.03% decline year-over-year.
- Allurion Technologies, Inc. inventory write-down for the quarter ending 2025-09-30 was $55.00K, a 91.95% decline year-over-year.
- Allurion Technologies, Inc. inventory write-down for the quarter ending 2025-06-30 was $419.00K, a 161.88% increase year-over-year.
- Allurion Technologies, Inc. inventory write-down for fiscal 2025 was $1.22M, a 45.42% decline from fiscal 2024.
- Allurion Technologies, Inc. inventory write-down for fiscal 2024 was $2.23M, a 59.26% increase from fiscal 2023.
- Allurion Technologies, Inc. inventory write-down for fiscal 2023 was $1.40M.
| Period end | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 9 month | Inventory Write-down 12 month |
|---|---|---|---|---|
| 2026-03-31 | $433.00K 10-Q · filed 2026-05-15 | $1.15M derived: sum of 2 quarters · filed 2026-05-15 | $1.21M derived: sum of 3 quarters · filed 2026-05-15 | $1.62M derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-12-31 | $717.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $772.00K derived: sum of 2 quarters · filed 2026-03-30 | $1.19M derived: sum of 3 quarters · filed 2026-03-30 | $1.22M 10-K · filed 2026-03-30 |
| 2025-09-30 | $55.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | $474.00K derived: sum of 2 quarters · filed 2025-11-17 | $499.00K 10-Q · filed 2025-11-17 | $1.68M derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-06-30 | $419.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-19 | $444.00K 10-Q · filed 2025-08-19 | $1.62M derived: sum of 3 quarters · filed 2026-05-15 | $2.30M derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-03-31 | $25.00K 10-Q · filed 2026-05-15 | $1.20M derived: sum of 2 quarters · filed 2026-05-15 | $1.88M derived: sum of 3 quarters · filed 2026-05-15 | $2.04M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $1.86M derived: sum of 2 quarters · filed 2026-03-30 | $2.02M derived: sum of 3 quarters · filed 2026-03-30 | $2.23M 10-K · filed 2026-03-30 |
| 2024-09-30 | $683.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2025-11-17 | $843.00K derived: sum of 2 quarters · filed 2025-11-17 | $1.05M 10-Q · filed 2025-11-17 | $1.71M derived: sum of 4 quarters · filed 2025-11-17 |
| 2024-06-30 | $160.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2025-08-28 | $369.00K 10-Q/A · filed 2025-08-28 | $1.02M derived: sum of 3 quarters · filed 2025-08-28 | $1.30M derived: sum of 4 quarters · filed 2025-08-28 |
| 2024-03-31 | $209.00K 10-Q/A · filed 2025-08-28 | $865.00K derived: sum of 2 quarters · filed 2025-08-28 | $1.14M derived: sum of 3 quarters · filed 2025-08-28 | |
| 2023-12-31 | $656.00K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2025-08-28 | $930.00K derived: sum of 2 quarters · filed 2025-08-28 | $1.40M 10-K/A · filed 2025-08-28 | |
| 2023-09-30 | $274.00K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2025-08-28 | $743.00K 10-Q/A · filed 2025-08-28 | ||
| 2023-06-30 | $469.00K 10-Q/A · filed 2025-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B |